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Background: After endoscopic submucosal dissection of gastric neoplasms, surveillance endoscopy is 
required for patients with synchronous or metachronous neoplasms. We aimed to evaluate the risk factors 
associated with surveillance loss in patients who underwent endoscopic submucosal dissection.
Methods: Ninety-five patients treated with endoscopic submucosal dissection for gastric neoplasms between 
May 2015 and June 2016 were retrospectively reviewed. Clinicopathologic factors, sociodemographic factors, 
psychiatric measures, and associated risk factors for surveillance loss were evaluated. The chi-square or 
Fisher exact test, t-test, and logistic regression analysis were used in data analysis.
Results: Twenty-five (26.3%) patients were identified as having surveillance loss. Compared to the 
surveillance group, the surveillance loss group was old and had dysplasia, and a healthy American Society 
of Anesthesiologists physical status. Similarly, surveillance loss was related to low symptom perception, 
low incidence of alexithymia, mindful awareness, and high trait forgiveness. Logistic regression analysis 
showed that dysplasia (odds ratio, 15.23; 95% CI, 1.56–149.09, P=0.019), old age (odds ratio, 7.14; 95% CI, 
1.90–26.88, P=0.004), and American Society of Anesthesiologists physical status 1 (odds ratio, 3.99; 95% CI, 
1.09–14.60, P=0.037) were associated with surveillance loss.
Conclusions: Dysplasia, old age, and the American Society of Anesthesiologists physical status 1 were 
associated with surveillance loss in patients who underwent gastric endoscopic submucosal dissection. It 
could be helpful to proactively monitor patients with such conditions after gastric endoscopic submucosal 
dissection.
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Introduction
Gastric cancer is the fourth most common cancer worldwide, 
especially in East Asian countries, including Korea (1). Due 
to the generalization of upper gastrointestinal endoscopy 
and Korean National Cancer Screening Programs for 
gastric cancer and an increase in public awareness of health 
check-ups, many people are undergoing endoscopy. This 
contributes significantly to the early detection of early gastric 
cancer (EGC), and the incidence of dysplasia is increasing. 
Gastric dysplasia is a progenitor lesion of gastric cancer, 
and diagnosis and treatment for dysplasia are important 
for early detection and prevention of gastric cancer (2). 
Endoscopic submucosal dissection (ESD) is a widely used 
treatment for gastric neoplasms (including gastric dysplasia 
or EGC) (3,4). ESD is effective, safe, and less invasive for 
gastric neoplasms. Many patients have been monitored 
regularly after ESD. During the follow-up, metachronous 
or synchronous neoplasm (MSN) is discovered at higher 
rates in patients who have undergone ESD than in those 
who have undergone surgery (5-7). Previous studies found 
that the incidence of synchronous and metachronous lesion 
recurrence after ESD for gastric neoplasms vary from 12.1% 
to 27.9% and from 3.6% to 16%, respectively (5,6,8-11). 
Therefore, regular surveillance with endoscopy is important 
for the early detection of MSN recurrence after ESD. Some 
studies have reported endoscopic surveillance strategies; 
however, methods and protocols for endoscopic surveillance 
have not been established after ESD for gastric neoplasms.
To the best  of  our knowledge,  no studies have 
investigated the risk factors for loss to follow-up in 
surveillance endoscopy after ESD. Therefore, this study 
aimed to retrospectively evaluate the characteristics and 
risk factors associated with surveillance endoscopy loss in 
patients who underwent ESD. We present the following 
article in accordance with the STROBE reporting checklist 
(available at https://dx.doi.org/10.21037/atm-21-891).
Methods
Study design and population
Patients with gastric neoplasm (including EGC or 
dysplasia) who underwent ESD at the National Health 
Insurance Service Ilsan Hospital in Korea between May 
2015 and June 2016 were evaluated retrospectively. We 
retrospectively evaluated the prospectively collected ESD 
results from the endoscopic database system. During this 
period, we conducted a prospective study of associated risk 
factors for distress in patients undergoing gastric ESD (12). 
Therefore, we similarly collected data of various psychiatric 
measures that can affect individual behavior retrospectively. 
After ESD, we collected only the data of patients who 
consented to follow-up in our hospital. Patients with 
cognitive impairment or neurological diseases, those who 
underwent subtotal gastrectomy, those with more than one 
gastric lesion, and those who needed a second ESD were 
excluded. The study was conducted in accordance with the 
Declaration of Helsinki (as revised in 2013). The study was 
approved by the Institutional Review Board of National 
Health Insurance Service Ilsan Hospital (number: 2020-03-
014) and individual consent for this retrospective analysis 
was waived.
Endoscopic submucosal dissection
The ESD procedures in our institution has been described 
in detail in a previous study (13). Briefly, ESD consists of 
three steps as follows: (I) injecting fluid into the submucosal 
layer around the lesion; (II) circumferential cutting of 
the mucosa at the marks surrounding the lesion; and 
(III) submucosal dissection of the tissue under the lesion 
with an electrosurgical knife. A single endoscopist (HHJ) 
performed all the ESD procedures. Therefore, the details 
of ESD (prognosis and surveillance endoscopy schedule) 
were explained to the patients by the same clinician. In this 
study, we investigated Helicobacter pylori (H. pylori) infection 
by Gimesa staining of biopsy specimens of the antrum and 
body and rapid urease test (CLO® test; Delta West, Bently, 
Australia) and administered eradication treatment for all 
patients with H. pylori infection after ESD.
Follow-up after ESD
The first surveillance endoscopy was performed within 
two to three months after ESD to assess the healing of 
post-ESD-induced artificial ulcers and the presence of any 
residual tumor. In patients with dysplasia, we recommend 
that a follow-up endoscopy be performed annually to detect 
metachronous lesions; additionally, in patients with EGC, we 
recommend that follow-up be performed every six months 
for five years to detect MSN. Generally, we emphasize 
that patients should at least undergo the Korean National 
Cancer Screening Programs for gastric cancer using upper 
endoscopy, which is performed every two years. All patients 
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were followed up for four years from the date of ESD
Data assessment
The patients were admitted the day before the ESD 
p r o c e d u r e .  B a s e l i n e  c h a r a c t e r i s t i c s ,  i n c l u d i n g 
sociodemographic factors, were collected for each patient 
on the day before ESD. The socioeconomic status was 
assessed by self-classification into one of the three pre-
defined socioeconomic status categories presented by 
the levels of three domains including income, education, 
and occupation (14,15). Self-report scales, including the 
European Organization for Research and Treatment of 
Cancer Core QOL Questionnaire 30 (EORTC QLQ-C30), 
the Korean version of the 20 item Toronto Alexithymia 
Scale (TAS-20K), Trait Forgivingness Scale-Korean 
(TFS-K), and Korean version of the Mindful Attention 
Awareness Scale (K-MAAS) were similarly administered on 
the day before ESD.
Psychiatric measures
Four self-report scales (EORTC QLQ-C30, TAS-20K, 
TFS-K, and K-MAAS) were used in this study. The 
K-MAAS is a 15-item scale designed to assess a core 
characteristic of mindfulness, which is a receptive state of 
mind in which attention, informed by a sensitive awareness 
of what is occurring in the present, simply observes what is 
happening (16). The EORTC QLQ-C30 was developed by 
the European Organization for Research and Treatment of 
Cancer Core QOL researchers in 1986 and is widely used 
in international clinical research on health-related quality of 
life in patients with cancer (17). It consists of 30 questions, 
including five functional scales (physical, social, role, 
cognitive, and emotional function), eight symptom scales 
(fatigue, nausea/vomiting, pain, dyspnea, sleep disturbances, 
appetite loss, constipation, and diarrhea), financial 
impact, and overall health status. We specifically used 
the symptom scale items in the scale because we thought 
that the degree of symptoms felt by the patient could play 
an important role in the maintenance of follow-up. The 
TAS-20K consists of three subscales as follow: Difficulty 
Identifying Feelings, Difficulty Describing Feelings, and 
Externally Oriented Thinking (18). The validity and 
reliability studies revealed that the cut-off point indicating 
alexithymia was 61. The TFS-K is a measure that reflects 
the tendency toward forgiveness; among the five factors of 
personality characteristics, it reflects a positive correlation 
with agreeableness, conscientiousness, extroversion, and 
openness, and a negative correlation with neuroticism (19).
Definitions
En bloc resection was defined as the resection of the 
neoplasm without a residual neoplasm on endoscopy. 
Complete resection was defined as the resection of the 
neoplasm that yielded histologically confirmed tumor-
free lateral and vertical margins. The follow-up period 
was defined from the date of the initial ESD to the date 
of the last upper endoscopy examination. There is no 
established consensus on effective surveillance strategies 
after ESD. Previous studies reported that annual or 
biannual surveillance endoscopy is the appropriate interval 
after ESD (20,21). Therefore, in this study, surveillance 
loss was defined as surveillance not being performed within 
one year to detect synchronous lesions and subsequently 
not undergoing follow-up endoscopy at a two-year interval 
for metachronous lesions
Statistical analysis
Categorical data were analyzed using the chi-square or 
Fisher exact test, whereas continuous data were analyzed 
using the t-test. Logistic regression analysis was used 
to identify the factors associated with surveillance loss 
after ESD. Values of P<0.05 were considered statistically 
significant, and data analysis was performed using SPSS 
version 23 (IBM Corp., Armonk, NY, USA).
Results
Patient characteristics
As shown in Table 1, 58 (61.1%) patients were men, and 
most patients (78.9%) reported being married. An analysis 
of the American Society of Anesthesiologists (ASA) physical 
status showed that 73 (76.9%) patients were classified 
into group 1 or 2, and 11 patients (11.6%) had psychiatric 
comorbidities. The gastric epithelial neoplasm lesion was 
located at the antrum in 59 cases (62.1%), and the size of 
most lesions (76.8%) was 10–20 mm. Fifty-seven patients 
(60%) were diagnosed with low grade dysplasia, 10 patients 
(10.5%) were diagnosed with high grade dysplasia, and 
28 patients (29.5%) were diagnosed with EGC. The rates 
of en bloc resection and complete resection were both 
97.9% (93/95). The mean scores of the EORTC QLQ-C30 
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symptom scale, TAS-20K, TFS-K, and K-MASS were 
18.14, 50.21, 34.46, and 36.36, respectively. Detailed data 
are shown in Table 1.
Comparison between the surveillance and surveillance loss 
groups
Table 2 compares sociodemographic and clinical factors 
between patients in the surveillance and the surveillance 
loss groups. Among the 95 patients, 25 (26.3%) were 
identified as having surveillance loss. No differences in sex, 
marital status, education level, or socioeconomic status were 
observed between the surveillance and surveillance loss 
groups. Similarly, the groups did not differ in psychiatric 
comorbidity, alcohol and smoking histories, lesion location, 
and lesion size. The surveillance loss group had a higher 
proportion of older patients (≥75 years) and patients with 
an ASA physical status of one than the surveillance group 
(P=0.007 and P=0.033, respectively). Additionally, the 
surveillance group had a higher proportion of patients 
with EGC than the surveillance loss group (P=0.001). The 
EORTC QLQ-C30 symptom scores differed significantly 
between the groups, with higher symptom scores in the 
surveillance group than in the surveillance loss group 
(P=0.032). The TAS-20K revealed that the surveillance 
group had a higher incidence of alexithymia than the 
surveillance group (P=0.027). The surveillance loss group 
showed higher TFS-K scores than the surveillance group 


































Low grade dysplasia 57 (60.0)
High grade dysplasia 10 (10.5)




En bloc resection 93 (97.9)
Complete resection 93 (97.9)




Values are expressed as mean ± SD or n (%). aPsychiatric 
comorbidity included depression, panic disorder, and sleep 
disorder. SD, standard deviation; ASA, American Society of 
Anesthesiologists; EORTC QLQ-C30, European Organization 
for Research and Treatment of Cancer Core QOL Questionnaire 
30; TAS-20K, Korean version of the 20 item Toronto Alexithymia 
Scale; TFS-K, Trait Forgivingness Scale-Korean; K-MASS, 
Korean version of the Mindful Attention Awareness Scale. 
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Table 2 Comparison between the surveillance and surveillance loss groups
Characteristic Surveillance group (n=70) Surveillance loss group (n=25) P value
Age (≥75 y) 12 (17.1) 11 (44.0) 0.007
Sex 0.546
Male 44 (62.9) 14 (56.0)
Female 26 (37.1) 11 (44.0)
Marriage status 0.674
Married 56 (80.0) 19 (76.0)
Unmarrieda 14 (20.0) 6 (24.0)
Education (y) 0.119
<7 12 (17.1) 8 (32.0)
7–12 46 (65.8) 16 (64.0)
>12 12 (17.1) 1 (4.0)
Socioeconomic status 0.904
Low 10 (14.3) 3 (12)
Middle 47 (67.1) 18 (72)
High 13 (18.6) 4 (16)
ASA physical status
1 11 (15.7) 9 (36.0) 0.033
Psychiatric comorbidityb 10 (14.3) 1 (4.0) 0.168
Substance use
Alcohol 26 (37.1) 11 (44.0) 0.546
Smoking 11 (15.7) 5 (20.0) 0.623
Lesion location 0.488
Lower 54 (77.1) 22 (88.0)
Middle 9 (12.9) 2 (8.0)
Upper 7 (10.0) 1 (4.0)
Lesion size (mm) 0.147
<10 10 (14.3) 3 (12.0)
10–20 51 (72.9) 22 (88.0)
>20 9 (12.8) 0 (0.0)
Histopathology 0.001
Dysplasia 43 (61.4) 24 (96.0)
Early gastric cancer 27 (38.6) 1 (4.0)
En bloc resection 69 (98.6) 24 (96.0) 0.459
Complete resection 69 (98.6) 24 (96.0) 0.459
EORTC QLQ-C30 symptom score 19.82±13.43 13.44±9.74 0.032
Table 2 (continued)
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Table 2 (continued)
Characteristic Surveillance group (n=70) Surveillance loss group (n=25) P value
TAS-K20 (score ≥61) 12 (17.1) 0 (0.0) 0.027
TFS-K score 33.83±4.85 36.24±4.7 0.034
K-MAAS score 37.97±11.45 31.84±10.46 0.021
Values are expressed as mean ± SD or n (%). aUnmarried includes single, divorced, and widowed status. bPsychiatric comorbidity included 
depression, panic disorder, and sleep disorder. SD, standard deviation; ASA, American Society of Anesthesiologists; EORTC QLQ-C30, 
European Organization for Research and Treatment of Cancer Core QOL Questionnaire 30; TAS-20K, Korean version of the 20 item 
Toronto Alexithymia Scale; TFS-K, Trait Forgivingness Scale-Korean; K-MASS, Korean version of the Mindful Attention Awareness Scale. 
(P=0.034); in contrast, the surveillance group showed higher 
K-MASS scores than the surveillance loss group (P=0.021).
Risk factors related to surveillance loss
Logistic regression analysis was performed to identify 
the risk factors for surveillance loss (Table 3). Univariable 
logistic regression analysis revealed that gastric dysplasia, 
old age (≥75 years), ASA physical status 1, quality of life 
(EORTC QLQ-C30 symptom scale), alexithymia (TAS-
20K), and mindful awareness (K-MAAS) were associated 
with surveillance loss. Additionally, multivariable logistic 
regression analysis showed that dysplasia [odds ratio (OR), 
15.23; 95% CI, 1.56–149.09, P=0.019), old age (≥75 years) 
(OR, 7.14; 95% CI, 1.90–26.88, P=0.004), and ASA physical 
status 1 (OR, 3.99; 95% CI, 1.09–14.60, P=0.037) were risk 
factors related to surveillance loss.
Discussion
ESD is an advanced endoscopic technique that is widely 
accepted as a standard treatment for selected cases of 
gastric neoplasms (3,4). In addition, ESD, compared with 
surgical resection, allows preservation of the stomach and 
helps maintain a better quality of life (22). However, ESD 
has a higher risk of MSN in the remnant stomach than 
surgical resection (5,8,11). Therefore, regular surveillance 
is required for the early detection of lesion recurrence, and 
it is important to identify risk factors related to surveillance 
loss after ESD.
We evaluated differences in psychiatric status between 
the surveillance and surveillance loss groups. The EORTC 
QLQ-C30 symptom scale, TAS-20K, TFS-K, and K-MAAS 
scores were significantly different between the groups. The 
EORTC QLQ-C30 symptom scale measures the severity of 
Table 3 Univariable and multivariable logistic regression analyses of surveillance loss
Characteristic
Univariable analysis Multivariable analysis
OR (95% CI) P value OR (95% CI) P value
Dysplasia 15.07 (1.93–117.94) 0.010 15.23 (1.56–149.09) 0.019
Age (≥75 y) 3.80 (1.40–10.37) 0.009 7.14 (1.90–26.88) 0.004
ASA physical status 1 3.02 (1.07–8.53) 0.037 3.99 (1.09–14.60) 0.037
EORTC QLQ-C30 symptom score 0.95 (0.91–1.00) 0.036
TFS-K score 1.11 (1.01–1.22) 0.038
K-MAAS score 0.95 (0.91–0.99) 0.024  .
OR, odds ratio; CI, confidence interval; ASA, American Society of Anesthesiologists; EORTC QLQ-C30, European Organization for 
Research and Treatment of Cancer Core QOL Questionnaire 30; TFS-K, Trait Forgivingness Scale-Korean; K-MASS, Korean version of the 
Mindful Attention Awareness Scale.
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symptoms, such as fatigue, pain, nausea, and vomiting, over 
the past week (17). The higher the score, the more severe 
the related symptoms, and patients in the surveillance group 
may have experienced more symptoms and undergone more 
follow-ups with awareness than those in the surveillance 
loss group. The TAS-20K is a measure of the level of 
alexithymia. A score of 61 or higher indicates alexithymia, 
a score of 52–60 indicates a borderline state, and a score 
of 51 or less indicates the absence of alexithymia (18). 
Alexithymia was more frequently observed in the 
surveillance group than in the surveillance loss group in this 
study. Alexithymia has been reported to be related to high 
anxiety, and high anxiety about one’s health status may lead 
to continued surveillance (23-25). The TFS-K is a measure 
that reflects trait forgiveness, which means the tendency 
to forgive, and trait forgiveness has been reported to be 
negatively correlated with neuroticism-related anxiety (19). 
In this study, the TFS-K score was significantly lower in the 
surveillance group than in the surveillance loss group, which 
may also indirectly indicate the possibility of continuing 
follow-up due to the high anxiety for disease recurrence. 
The K-MAAS is a measure for evaluating attention 
and awareness, the major elements of mindfulness (16). 
According to Bishop et al., mindfulness is a form of 
awareness, and it is characterized by “self-regulation of 
attention that enables awareness of the present moment 
experience” (26). The K-MAAS score of the surveillance 
group was significantly higher than that of the surveillance 
loss group. This is because the current attention and 
awareness of symptoms of patients in the surveillance 
groups were relatively high compared to those in the 
surveillance loss group. Therefore, they probably perceived 
their symptoms more frequently and continued follow-up.
Logistic regression analysis showed that the risk factors 
for surveillance loss after ESD were dysplasia, old age 
(≥75 years), and normal health (ASA physical status of one) 
without psychiatric factors. The reason for this finding is 
unclear. Patients may often underestimate the importance 
of surveillance endoscopy due to the misconception that 
gastric neoplasm slowly develops in older patients, leading 
to a false sense of relief that dysplasia is less invasive 
than EGC. Patients may not have been followed up with 
surveillance because they were healthy and experienced no 
specific symptoms after ESD. It is crucial to consider the 
risk of MSN in the remnant stomach and the importance of 
surveillance.
The clinical significance of this study is as follows: First, 
the risk factors for surveillance loss were analyzed, including 
sociodemographic, psychiatric, and clinicopathological 
factors. This is because patients are affected by various factors 
when considering to undergo surveillance endoscopy. Second, 
when gastric dysplasia is diagnosed, there is a high possibility 
that synchronous dysplasia or gastric cancer is present 
(11,27,28), and it is highly likely to develop metachronous 
dysplasia or gastric cancer (10,11,28,29). Yoon et al. showed 
that the incidence of gastric cancer after endoscopic resection 
for gastric dysplasia was similar to that of EGC (10). There 
are several previous studies on the risk factors for recurrence 
after endoscopic resection. These studies reported that 
recurrence was more frequent in patients with multiple 
synchronous lesions, old age, intestinal metaplasia, and 
undifferentiated histology of EGC (11,30-32). In other words, 
older age is a risk factor for recurrence after endoscopic 
resection and surveillance loss after endoscopic resection. 
The elderly population is growing with an increased 
incidence of gastric neoplasm, and, in a previous study, the 
incidence of metachronous recurrence generally increased 
steadily over five years and plateaued at 10 years (20). 
In elderly patients, ESD is an effective and safe therapy 
compared to surgery due to comorbidity (33,34). The long-
term outcome of ESD for elderly patients is favorable, and 
this outcome is not significantly different from those in 
younger patients (35). Therefore, even if elderly patients 
with gastric neoplasm are healthy, surveillance endoscopy is 
necessary after the initial ESD.
Our study has several limitations. First, there is a risk 
of selection bias due to the retrospective and single-
center study design. However, the risk may have been 
reduced because prospectively collected data were used. 
Second, the sample size was not sufficient to generalize our 
results. Third, surveillance was explained using the same 
explanatory materials after ESD, and only one endoscopist 
was responsible for explaining surveillance in our study. 
How the disease and surveillance strategies were explained 
to the patient may have affected the patients’ decision 
to undergo surveillance endoscopy after ESD. Hence, 
multicenter prospective studies should be performed to 
evaluate the risk factors for surveillance.
In conclusion, this study revealed that older age, normal 
health, and gastric dysplasia were associated with greater 
loss to follow-up in patients undergoing gastric ESD. It 
could be helpful to screen and further proactively monitor 
patients after performing gastric ESD, which may improve 
surveillance after ESD.
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